AMA votes no on Medicare for all

As Medicare for all continues to gain traction among American voters and more Democratic presidential nominees take up the platform, the American Medical Association has decided not to support such an initiative.

The group, which represents physicians, voted on its new policies and leadership during its annual meeting in Chicago at the beginning of June. Instead of adopting Medicare for all, which provides universal healthcare through a single payer, the AMA opted to pursue policies that strengthen the Affordable Care Act.

During the meeting, the AMA’s House of Delegates––­­its policymaking body—voted 53% to 47% against a measure that would have dropped a decades-long opposition to a single-payer system, The Hill reported.

The AMA reaffirmed its commitment to the ACA during the meeting, citing new recommendations that recognize the healthcare law is “not broken, but it is imperfect.” The association’s goal with the ACA is to improve access to health insurance coverage to the uninsured. That includes expanding the amount of and eligibility for premium tax credits, removing the subsidy cliff, increasing cost-sharing reductions received by those who are qualified, and extending eligibility for cost-sharing reductions beyond 250% of the family poverty level.

“Since the ACA was enacted into law in 2010, millions of Americans have gained health insurance,” AMA President Barbara L. McAneny, MD, said in a statement. “The policy question now is how to improve the law to insure even more. We need policies to make coverage more affordable for millions of Americans­­––both in the premiums they pay, as well as their cost-sharing responsibilities.” 

In addition to voting on healthcare policies that aim to expand coverage, the AMA elected its future leadership and swore in its new president.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.